vs
Side-by-side financial comparison of FEDERAL AGRICULTURAL MORTGAGE CORP (AGM) and Axsome Therapeutics, Inc. (AXSM). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $107.5M, roughly 1.8× FEDERAL AGRICULTURAL MORTGAGE CORP). On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 6.1%). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 7.1%).
The Federal Agricultural Mortgage Corporation, also known as Farmer Mac, is a stockholder-owned, federally chartered corporation established by the U.S. Congress in 1988 under the Agricultural Credit Act of 1987. It was created to establish a secondary market for agricultural real estate and housing mortgage loans, to increase liquidity and the availability of long-term, stable credit for farmers, ranchers, and rural communities.
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
AGM vs AXSM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $107.5M | $196.0M |
| Net Profit | — | $-28.6M |
| Gross Margin | — | — |
| Operating Margin | 56.3% | -13.8% |
| Net Margin | — | -14.6% |
| Revenue YoY | 6.1% | 65.0% |
| Net Profit YoY | — | 61.9% |
| EPS (diluted) | $3.69 | $-0.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $107.5M | $196.0M | ||
| Q3 25 | $104.0M | $171.0M | ||
| Q2 25 | $102.6M | $150.0M | ||
| Q1 25 | $94.3M | $121.5M | ||
| Q4 24 | $101.3M | $118.8M | ||
| Q3 24 | $90.3M | $104.8M | ||
| Q2 24 | $89.9M | $87.2M | ||
| Q1 24 | $93.7M | $75.0M |
| Q4 25 | — | $-28.6M | ||
| Q3 25 | $55.0M | $-47.2M | ||
| Q2 25 | $54.8M | $-48.0M | ||
| Q1 25 | $49.7M | $-59.4M | ||
| Q4 24 | $56.5M | $-74.9M | ||
| Q3 24 | $49.8M | $-64.6M | ||
| Q2 24 | $47.1M | $-79.3M | ||
| Q1 24 | $53.7M | $-68.4M |
| Q4 25 | 56.3% | -13.8% | ||
| Q3 25 | 64.1% | -27.0% | ||
| Q2 25 | 63.8% | -24.5% | ||
| Q1 25 | 66.9% | -46.9% | ||
| Q4 24 | 67.5% | -61.1% | ||
| Q3 24 | 69.0% | -59.8% | ||
| Q2 24 | 65.9% | -89.5% | ||
| Q1 24 | 72.8% | -89.7% |
| Q4 25 | — | -14.6% | ||
| Q3 25 | 52.9% | -27.6% | ||
| Q2 25 | 53.4% | -32.0% | ||
| Q1 25 | 52.6% | -48.9% | ||
| Q4 24 | 55.8% | -63.1% | ||
| Q3 24 | 55.2% | -61.7% | ||
| Q2 24 | 52.4% | -91.0% | ||
| Q1 24 | 57.4% | -91.1% |
| Q4 25 | $3.69 | $-0.55 | ||
| Q3 25 | $4.44 | $-0.94 | ||
| Q2 25 | $4.48 | $-0.97 | ||
| Q1 25 | $4.01 | $-1.22 | ||
| Q4 24 | $4.62 | $-1.54 | ||
| Q3 24 | $3.86 | $-1.34 | ||
| Q2 24 | $3.68 | $-1.67 | ||
| Q1 24 | $4.28 | $-1.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $322.9M |
| Total DebtLower is stronger | $30.8B | — |
| Stockholders' EquityBook value | $1.7B | $88.3M |
| Total Assets | $35.4B | $689.8M |
| Debt / EquityLower = less leverage | 17.93× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $322.9M | ||
| Q3 25 | — | $325.3M | ||
| Q2 25 | — | $303.0M | ||
| Q1 25 | — | $300.9M | ||
| Q4 24 | — | $315.4M | ||
| Q3 24 | $842.1M | $327.3M | ||
| Q2 24 | $923.0M | $315.7M | ||
| Q1 24 | $745.1M | $331.4M |
| Q4 25 | $30.8B | — | ||
| Q3 25 | $29.2B | — | ||
| Q2 25 | $28.9B | — | ||
| Q1 25 | $28.0B | — | ||
| Q4 24 | $27.5B | — | ||
| Q3 24 | $27.2B | — | ||
| Q2 24 | $26.8B | — | ||
| Q1 24 | $26.8B | — |
| Q4 25 | $1.7B | $88.3M | ||
| Q3 25 | $1.7B | $73.7M | ||
| Q2 25 | $1.5B | $73.1M | ||
| Q1 25 | $1.5B | $53.2M | ||
| Q4 24 | $1.5B | $57.0M | ||
| Q3 24 | $1.5B | $92.9M | ||
| Q2 24 | $1.5B | $102.9M | ||
| Q1 24 | $1.5B | $144.0M |
| Q4 25 | $35.4B | $689.8M | ||
| Q3 25 | $33.4B | $669.3M | ||
| Q2 25 | $33.0B | $639.8M | ||
| Q1 25 | $31.8B | $596.7M | ||
| Q4 24 | $31.3B | $568.5M | ||
| Q3 24 | $30.6B | $561.5M | ||
| Q2 24 | $30.2B | $548.2M | ||
| Q1 24 | $29.8B | $545.7M |
| Q4 25 | 17.93× | — | ||
| Q3 25 | 17.31× | — | ||
| Q2 25 | 18.70× | — | ||
| Q1 25 | 18.39× | — | ||
| Q4 24 | 18.48× | — | ||
| Q3 24 | 18.60× | — | ||
| Q2 24 | 17.87× | — | ||
| Q1 24 | 18.11× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $80.1M | $-18.7M |
| Free Cash FlowOCF − Capex | — | $-18.7M |
| FCF MarginFCF / Revenue | — | -9.6% |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-93.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.1M | $-18.7M | ||
| Q3 25 | $74.2M | $1.0M | ||
| Q2 25 | $-47.7M | $-32.4M | ||
| Q1 25 | $-49.8M | $-43.4M | ||
| Q4 24 | $612.6M | $-26.2M | ||
| Q3 24 | $-44.4M | $-18.6M | ||
| Q2 24 | $56.1M | $-30.1M | ||
| Q1 24 | $233.3M | $-53.5M |
| Q4 25 | — | $-18.7M | ||
| Q3 25 | — | $988.0K | ||
| Q2 25 | — | $-32.4M | ||
| Q1 25 | — | $-43.7M | ||
| Q4 24 | $607.4M | $-26.2M | ||
| Q3 24 | $-44.4M | $-18.7M | ||
| Q2 24 | $52.6M | $-30.2M | ||
| Q1 24 | $231.7M | $-53.6M |
| Q4 25 | — | -9.6% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | -21.6% | ||
| Q1 25 | — | -36.0% | ||
| Q4 24 | 599.8% | -22.1% | ||
| Q3 24 | -49.2% | -17.9% | ||
| Q2 24 | 58.5% | -34.6% | ||
| Q1 24 | 247.3% | -71.4% |
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | 5.2% | 0.0% | ||
| Q3 24 | 0.1% | 0.1% | ||
| Q2 24 | 4.0% | 0.1% | ||
| Q1 24 | 1.7% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 1.35× | — | ||
| Q2 25 | -0.87× | — | ||
| Q1 25 | -1.00× | — | ||
| Q4 24 | 10.84× | — | ||
| Q3 24 | -0.89× | — | ||
| Q2 24 | 1.19× | — | ||
| Q1 24 | 4.34× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
